What does Kissei Pharmaceutical do with its cash?

Cash vs. profit gap

-¥15.3B（純利益の -110.8%）

Shareholder returns

of net income 73.0%

Shareholder payments — dividends

of net income 35.1%

CapEx intensity (capex ÷ revenue)

5.8%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

• Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
• Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
• Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.